Woolworths Group Ltd (ASX: WOW) has made a step towards its carbon emissions targets, signing its first renewable power purchase agreement. At the time of writing, the Woolworths share price is up 1%, with shares in the company trading for $43.35.

Woolworths shared the news of its power purchase – which will cover 30% of Woolworths’ supermarket’s electricity use – yesterday.

According to the group, its energy needs make up around 1% of Australia’s total energy use. Woolworths Group is aiming to be powered entirely by renewable energy by 2025.

Let’s take a closer look at Woolworths’ news.

Renewable power purchase agreement

Woolworths has signed a 10-year agreement with CWP Renewables to purchase power from the new Bango wind farm – located near Yass, NSW.

The agreement will see Woolworths paying to put 195,000 megawatt hours of renewable electricity into the NSW electricity grid each year. By doing so, it will avoid the release of 158,000 tonnes of carbon emissions annually.

Woolworths already has a network of 140 rooftop solar panels scattered around Australia.

The retail giant is aiming to cut its carbon emissions by 63% by 2030 and by 100% by 2050. It’s already reduced its emissions by 25% since 2015.

Woolworths is one of a handful of ASX companies to have its emission reduction targets backed by the United Nations Science-Based Target Initiative, which aims to limit global warming to 1.5 degrees.

Woolworths stated it plans to continue searching for opportunities to directly invest in renewable power purchases.

The Bango wind farm will begin producing power for Woolworths in early 2022.

Commentary from management

Woolworths Group’s director of format, Rob McCartney, commented on the power purchase agreement:

Going beyond net carbon neutral, we’ve committed to take more carbon out of the atmosphere than we produce by 2050 and our first renewable power purchase is a key milestone in that pursuit.

Supermarkets are particularly energy intensive to run and we want to use our scale for good by supporting the transition to renewable electricity.

Woolworths share price snapshot

The Woolworths share price has been performing well on the ASX lately.

Currently, it’s 7.27% higher than it was at the start of this year. The Woolworths share price has also gained 17.27% since this time last year.

The group has a market capitalisation of around $54 billion, with approximately 1.2 billion shares outstanding.

The post Woolworths (ASX:WOW) inks first renewable power deal appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3uR1YFc

The S&P/ASX 200 Index (ASX: XJO) has slipped 0.1% from record all-time highs on Friday.

This follows a weak overnight performance on Wall Street with all three indices, the Nasdaq Composite (NASDAQ: .IXIC), S&P 500 Index (SP: .INX) and Dow Jones Industrial Average Index (DJX: .DJI) down between 0.07% and 1.03%.

Despite the slight pullback, ASX gold miners have taken a worse hit on Friday.

Large cap ASX gold miners including Northern Star Resources Ltd (ASX: NST), Evolution Mining Ltd (ASX: EVN) and Newcrest Mining Ltd (ASX: NCM) are currently down 4.10%, 3.20% and 1.73% respectively.

Mid-tier players such as Perseus Mining Ltd (ASX: PRU) and Ramelius Resources Ltd (ASX: RMS) are a little worse off, down 5.61% and 7.18% respectively, but Regis Resources Ltd (ASX: RRL) is faring better, down just 1.91%.

At the more speculative end of town, gold explorers have also taken a hit with popular names such as De Grey Mining Ltd (ASX: DEG) slumping 7.32% at the time of writing.

Higher treasury yields smacks gold prices

US bond yields ticked upwards on Thursday night in response to better than expected labour market data. The United States reported a surge in private-sector employment in May, while initial jobless claim figures came in within expectations.

Benchmark US 10-year treasury yields rose about 4 basis points to 1.626%. 10-year treasury yields have been range bound between 1.5% to 1.7% since March this year. This follows its meteoric rise from lows of 0.50% in August last year to a peak of 1.75% in late March.

Coinciding with the uptick in treasury yields and positive labour market data, gold prices slumped about 2% overnight from US$1,900 to US$1,870.

Why do treasury yields matter?

There is an opportunity cost when it comes to holding gold. The yellow metal does not bear any yield, so a capital flow from gold to bonds can be expected when yields become sufficiently high.

For most of last year, the opposite was happening as 10-year yields plunged from 1.95% pre-COVID to lows of 0.50% by August 2020. In conjunction with the fall in yields, gold prices surged from around US$1,650 to a peak of over US$2,060 on 6 August 2020.

Gold could be at its crossroads, with factors such as a weak US dollar and high inflation propping up prices, while a potential breakout of yields could send prices further south.

The post Why ASX gold miners are taking a hit today appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3g4Mzfq

Appen Ltd (ASX: APX) shares are falling this morning after the company’s chief executive officer sold a sizeable amount of his shareholding.

At the time of writing, the Appen share price is trading 4.9% lower at $12.42.

Why is the CEO selling?

According to the announcement by the artificial intelligence data provider, CEO Mark Brayan disposed of 109,430 shares last Friday. The sale was actioned at $13.0805 per share — an approximate total sale value of $1.43 million.

Whenever a CEO cashes out of the company they are leading, eyebrows are raised. So, why has Brayan sold down his holding?

The company’s release specifies the sale was to satisfy tax obligations arising from the vesting of 173,153 performance rights in March.

Post-sale, Brayan retains 482,032 shares in the company. On that basis, this recent sale would represent a selldown of roughly 18.5% of Mr Brayan’s holdings in Appen.

Poor timing for Appen share price

Usually, shareholders aren’t too bothered by management taking some pocket change for their efforts. However, cashing out after a period of share price underperformance is a surefire way to leave investors with a bitter taste.

The Appen share price has fallen approximately 70% from its high back in August last year. Disappointment has lingered since the company issued a guidance downgrade in December, following a sluggish quarter.

More recently the shares have rebounded somewhat after the company announced a business restructuring. The move to reposition Appen with four distinct business units — Global, Enterprise, China, and Government — seemed to restore some shareholder optimism.

However, today’s down move indicates shareholders may feel the restructure alone isn’t enough to warrant a $1.4 million payday for the CEO.

Looking ahead

Shareholders will be hoping Appen delivers on its full-year guidance, which was reaffirmed in May. Between US$83 million and US$90 million is expected in underlying earnings before interest, tax, depreciation, and amortisation (EBITDA).

Once a growth company starts missing forecasts, it can get ugly quickly. The Appen share price will be skating on thin ice if FY21’s result disappoints — especially after seeing the CEO reduce his own interests in the company.

The post Here’s why the Appen (ASX:APX) share price is falling 5% today appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3uPSM4a

The Adriatic Metals PLC (ASX: ADT) share price is gaining in morning trade, up 2% at time of writing.

Below we look at the ASX silver company’s latest permitting success.

What did Adriatic Metals report?

The Adriatic Metals share price is gaining after the company announced the Bosnian Federal Ministry of Spatial Planning had greenlighted the Urban Planning Permit (UPP) for its Rupice underground deposit.

The Rupice deposit makes up part of the silver explorer’s Vares silver project in Bosnia and Herzegovina. It received the UPP for the other part of the Vares silver project – called Veovaca – in November 2020, with an exploitation licence granted in January. The company said Veovaca received its permits earlier because it’s a brownfield open pit deposit, whereas Rupice is a greenfield underground deposit.

Adriatic Metals said receipt of the permits involved approval from significant government stakeholders, including neighbouring municipalities, as well as local commercial service providers.

Commenting on the permit, Adriatic Metal’s CEO, Paul Cronin, said:

The award of the UPP represents the last major step before obtaining the Rupice Exploitation Permit, which I remain confident it will be received within the coming weeks. Since Adriatic’s incorporation in March 2017, the company has worked very hard with the local community and the various levels of government to work through the project permitting process.

This award demonstrates the level of expertise in our team, as well as the support and cooperation from the local community and government in building the Vares Project.

Adriatic reported it will immediately apply for the exploitation permit, a technically focused process.

Construction can commence on receipt of the exploitation permit for Rupice, which will give Eastern Mining, Adriatic’s wholly owned Bosnian subsidiary, the right to mine and process ore at the Vares silver project.

How has the Adriatic Metals share price been performing?

Adriatic Metals’ share price is up 82% over the past 12 months. By comparison the All Ordinaries Index (ASX: XAO) has gained 23% over that same time.

Year-to-date, Adriatic shares have gained 9%.

The post Here’s why the Adriatic Metals (ASX:ADT) share price is gaining today appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3ig2kCX

The Ioneer Ltd (ASX: INR) share price is in freefall today. At the time of writing, shares in the lithium miner are trading at 31.5 cents each – down 17.1%.

The company’s precarious position comes after the US Fish and Wildlife Service (FWS) said it would declare the Tiehm’s Buckwheat that inhabits the site of its proposed Nevada lithium mine as an endangered species.

Let’s take a closer look at today’s news and why it might be worrying investors.

Ioneer share price tanks

In a blow to the Ioneer share price, the FWS says the proposed Rhyolite Ridge lithium mine would have a “permanent and irreversible” effect on the desert flower.

In the last northern summer, 40% of Tiehm’s Buckwheat, which are only found in Nevada, had been destroyed. Conservationists blamed Ioneer and its mine, but Ioneer blamed local wildlife. The FSA found it was mostly local squirrel populations, but that the mine did and would have an exacerbating impact on the plant.

In a statement to the ASX this morning, Ioneer said it has done “significant work” to transport the plant to other parts of the state. FWS, however, says this plan would likely fail because Tiehm’s Buckwheat does best in the soil that is found on top of the proposed lithium site.

While a final designation is not due until September and will not block the mine automatically, investors seem to think it could be a significant hindrance – judging by this morning’s performance of the Ioneer share price.

Management commentary

In a statement to the ASX this morning, Ioneer managing director Bernard Rowe said the company supports and expected today’s decision by the FWS.

Mr Rowe also says Ioneer can assist in preserving Tiehm’s Buckwheat from the threats of drought and small mammals in the area. He added that the company believes the Rhyolite Ridge mine and the Tiehm’s Buckwheat can coexist.

As the price of lithium is up 91.4% since the beginning of the year, it is unsurprising the company is keen to see this mine proceed as planned, despite today’s news. However, the reaction of the Ioneer share price today suggests investors may be less optimistic about its prospects.

Ioneer share price snapshot

Over the past 12 months, the Ioneer share price has increased by around 163%. Its value has been steadily appreciating as investors flock to lithium shares. Year to date, the company’s shares are up by around 13%.

Given its current valuation, Ioneer has a market capitalisation of $597 million.

The post Ioneer (ASX:INR) share price plummets 17% on new lithium mine hurdle appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/2RjPisP

The Creso Pharma Ltd (ASX: CPH) share price is on form again on Friday morning.

At the time of writing, the cannabis and psychedelics company’s shares are up 5.5% to 19.2 cents.

This means the Creso share price is now up a massive 35% in the space of just two days.

Why is the Creso share price racing higher?

Investors have been scrambling to buy Creso’s shares since the release of an announcement on Thursday.

That announcement revealed that the company is planning to expedite a Californian psychedelics market entry following the recent passing of Senate Bill 519.

Senate Bill 519, which remains subject to further regulatory approval from California’s lower house and the Governor of California, could make a wide range of psychedelic substances, including psilocybin, legal to use and possess for adults over the age of 21.

Creso is well-positioned to benefit from the regulatory shift through its soon-to-be acquired Halucenex Life Sciences business.

Halucenex specialises in psychedelic compounds and recently announced that had secured additional pharmaceutical grade psilocybin supply. This made it one of the largest holders of single batch GMP grade synthetic psilocybin in Canada.

Creso’s non-executive Chairman, Adam Blumenthal, commented: “This is a major development for Creso Pharma and Halucenex and provides a key strategy piece, which will underpin our expansion into the US market. Over the recent months, we have made a number of US focused appointments and Halucenex have secured multiple partnerships and agreements that will allow the Company to pursue the US psychedelics market and become a first mover in the sector.”

What else is supporting its shares?

Also giving the Creso share price a boost was the release of yet another announcement this morning.

Today’s announcement, its eighth in the space of a month, reveals that the company has extended its distribution agreement with Route 2 Pharm to allow for distribution of Creso’s products into Ecuador. This means the agreement now extends to 14 countries

Management commented: “Ecuador provides a large market opportunity for Creso Pharma as it recently passed legislation to approve the production, commercialisation, use and consumption of cannabis for medicinal or therapeutic treatment. The country has a population of over 15m and is part of the rapidly emerging medicinal cannabis market in the Latin American and Caribbean region, which has an estimated population of 655mii. Creso is confident that Ecuador will provide it with a strong foothold in the rapidly growing Latin American market, which is expected to grow to over US$300m in value by 2024.”

The post Why the Creso (ASX:CPH) share price is up 35% in two days appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3g5u6zf

Blue chip shares are leading companies that generally have strong business models, long track records, and products or services that dominate their respective markets.

It is because of these characteristics that they are considered to be quite stable and therefore lower risk options than the average share. For this reason, many investors will load up their portfolios with blue chip shares.

If you’re looking to do the same, then you might want to look at the two listed below. Here’s why they have been named as blue chips to buy:

Aristocrat Leisure Limited (ASX: ALL)

The first blue chip ASX share to consider is Aristocrat Leisure. It is one of the world’s leading gaming technology companies with a portfolio of world class poker machines and digital games.

It recently released its half year results, which revealed that Aristocrat has bounced back strongly from the pandemic. For the six months ended 31 March, the company reported a normalised net profit after tax (NPAT) of $362.2 million. This was an increase of 18.4% on the prior corresponding period.

Aristocrat’s profit growth was driven by strong performances from both its Gaming and Digital businesses. Positively, almost 80% of its revenue was derived from recurring sources during the period. This gives it a firm foundation to build on in the coming years.

This result went down well with analysts at Citi. In response, the broker retained its buy rating and lifted its price target to $46.00.

Healius Ltd (ASX: HLS)

Another blue chip share to look at is Healius. It is one of Australia’s largest pathology and diagnostic imaging providers in Australia.

Like Aristocrat, Healius has been performing very strongly in FY 2021. During the first half, it reported a 16% increase in revenue to $953.5 million and a massive 190% jump in net profit to $75.6 million.

A key driver of this growth was its pathology business, which reported a 22% increase in revenue to $711.4 million and significantly wider margins. This was thanks largely to its role in testing for COVID-19.

Positively, this strong form has continued, with Healius recently reported solid growth during the third quarter. Once again, COVID-19 testing played a key role in this strong form.

One broker that is particularly bullish on Healius is Macquarie. This morning the broker retained its outperform rating and lifted its price target to $4.70.

The post Top brokers have named these ASX blue chip shares as buys appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3prdG8I

The Noxopharm Ltd (ASX: NOX) share price is on course to end the week on a positive note.

In morning trade, the clinical-stage drug development company’s shares are up 3% to 72 cents.

This means the Noxopharm share price now up over 50% since the start of the year.

Why is the Noxopharm share price rising?

Investors have been buying Noxopharm shares following the release of an announcement this morning.

According to the release, headline data from the phase 3 VISION trial was released overnight. This trial looked at the effectiveness of Lu-PSMA-617 as a treatment for late-stage prostate cancer. Lu-PSMA-617 is owned by Novartis.

The release explains that Lu-PSMA-617 could become an important new treatment for late-stage prostate cancer on the basis of Phase 3 clinical trial data released overnight.

Why is this good news for Noxopharm?

This is potentially very good news for Noxopharm because its recent LuPIN trial data shows an even stronger survival outcome when Lu-PSMA-617 is combined with its own Veyonda product.

Noxopharm’s CEO and Managing Director, Dr Graham Kelly, said: “This result is positive news for Noxopharm for two reasons.”

“The first is that it confirms that Veyonda in combination with Lu-PSMA-617 provides a considerable survival advantage over Lu-PSMA-617 alone. The LuPIN mOS outcome of 19.7 months still remains the best survival outcome of any drug approved for use in men with endstage prostate cancer including enzalutamide, abiraterone, docetaxel, cabazitaxel, and now Lu-PSMA-617.”

“The second is that having Lu-PSMA-617 likely to come to market as a 3rd line therapy provides a clear development pathway now for Veyonda to come to market itself, with a distinct opportunity to make the Veyonda/Lu-PSMA-617 combination a new standard of care for endstage prostate cancer,” he concluded.

This sentiment was echoed by Noxopharm Chief Medical Officer, Dr Gisela Mautner.

Dr Mautner said: “Noxopharm welcomes this news because it has a major interest in seeing Lu-PSMA-617 come to market and become a standard of care for prostate cancer. The Company believes that the LuPIN study has demonstrated that Veyonda has the ability to enhance the efficacy of Lu-PSMA-617, with a greater survival benefit from the combination than Lu-PSMA-617 alone. This well-tolerated combination therapy should increase the attractiveness of radioligand therapy for men with late-stage prostate cancer even more.”

The post Why the Noxopharm (ASX:NOX) share price is charging higher again appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3uTzF9g

Some ASX shares have relatively small market capitalisations but they are capable of having quite high dividend yields.

The below businesses have yields that are higher than the market average:

360 Capital REIT (ASX: TOT)

360 Capital is a real estate investment trust (REIT) which invests in a wide range of property-related assets.

It has invested in a few different ASX shares in recent times. Peet Limited (ASX: PPC) is a residential developer that delivers master planned communities, medium density housing and apartments. Another investment was Irongate Group (ASX: IAP), which is a diversified real estate investor and it also has a third-party funds management platform.

360 Capital has also bought half of PMG Group, a New Zealand commercial real estate funds management business.

The forecast distribution guidance for FY21 is 6 cents per security, which translates to a forecast yield of 6.25%.

Pengana Capital Group Ltd (ASX: PCG)

Pengana is a fund manager that runs a number of different strategies including ASX shares, international shares and private equity. The company said that it’s looking to diversify over time by adding new strategies.

In the six months to December 2020, the ASX share said that funds under management (FUM) increased by 15% thanks to both investment performance and net inflows. All of its strategies outperformed their respective benchmarks for the period. The fund manager said that it’s growing FUM on higher margin products.

The Pengana Property Securities Fund was one of the latest products to be launched.

In the half-year result, Pengana grew its interim dividend by 25% to 5 cents per share. That brought the trailing annual payment to 9 cents per share, translating to a grossed-up dividend yield of 8%.

In the latest monthly FUM update, Pengana said its FUM had increased from $3.7 billion to $3.8 billion.

Pacific Current Group Ltd (ASX: PAC)

Pacific is an asset management ASX share that aims to partner with exceptional investment managers. It combines capital (offered through different economic structures) with strategic business development to help those investment managers grow.

Some of its investments include GQG, ROC, Carlisle, Proterra and Victory Park. Those were the ones that saw elevated inflows in the three months to 31 March 2021. It also acquired a stake in Astarte Capital Partners. In that same quarter, it experienced 8.9% organic FUM growth.

Over the last 12 months, Pacific Current has paid an annual dividend of $0.35 per share. That equates to a grossed-up dividend yield of 8.9%.

The post 3 small ASX shares with big dividend yields appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3uPy3xt

The Reject Shop Ltd (ASX: TRS) share price has come under significant pressure today following the release of a trading update.

At the time of writing, the discount retailer’s shares are down 15% to $5.37.

What did Reject Shop announce?

Reject Shop began by reminding the market that in February it warned that its sales were being impacted in the second half due to the Brisbane, Perth and Victoria lockdowns, COVID-19 concerns in New South Wales, and changing State border restrictions.

It also noted that its stores in CBD locations and large shopping centres continued to be negatively impacted by reduced footfall and that it was facing ongoing challenges in the international supply chain. That latter was expected to result in increased costs during the second half.

What’s the latest?

Unfortunately, since that update, trading activity has continued to be challenging.

Management advised that its stores in CBD locations and large shopping centres, typically in metropolitan areas, continue to trade well below pre COVID-19 levels.

As a result, preliminary and unaudited comparable sales for the 48 weeks ended 30 May 2021 were down 1.4% compared to the comparable period in FY 2019. This comprises a 12% decline in comparable sales at CBD locations and large shopping centres and a 0.9% lift in the remainder of its portfolio.

In addition, the company continues to incur materially increased supply chain costs, particularly higher international shipping costs, as well as costs associated with holding inventory due to international shipping delays.

Guidance

Although the company is aiming to offset the above through a reduction in costs, it isn’t going to be enough to stop Reject Shop from reporting a second half loss.

As a result, management expects full year sales of between $776 million and $778 million and earnings before interest and tax (EBIT) of $8 million to $10 million.

While the latter is higher than FY 2020’s EBIT, it is down markedly from its first half EBIT of $23.3 million.

The post Why the Reject Shop (ASX:TRS) share price is getting hammered appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/2SWyRDa